ATE414538T1 - Behandlung zur reduzierung der zunahme des körpergewichts - Google Patents

Behandlung zur reduzierung der zunahme des körpergewichts

Info

Publication number
ATE414538T1
ATE414538T1 AT03728557T AT03728557T ATE414538T1 AT E414538 T1 ATE414538 T1 AT E414538T1 AT 03728557 T AT03728557 T AT 03728557T AT 03728557 T AT03728557 T AT 03728557T AT E414538 T1 ATE414538 T1 AT E414538T1
Authority
AT
Austria
Prior art keywords
weight gain
treatment
body weight
reduce body
colipase
Prior art date
Application number
AT03728557T
Other languages
English (en)
Inventor
Douglas Stafford
John Kink
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Application granted granted Critical
Publication of ATE414538T1 publication Critical patent/ATE414538T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
  • Disintegrating Or Milling (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
AT03728557T 2002-04-26 2003-04-24 Behandlung zur reduzierung der zunahme des körpergewichts ATE414538T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37616602P 2002-04-26 2002-04-26
US10/421,393 US20040018197A1 (en) 2002-04-26 2003-04-23 Treatment for weight loss

Publications (1)

Publication Number Publication Date
ATE414538T1 true ATE414538T1 (de) 2008-12-15

Family

ID=29273052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03728557T ATE414538T1 (de) 2002-04-26 2003-04-24 Behandlung zur reduzierung der zunahme des körpergewichts

Country Status (7)

Country Link
US (1) US20040018197A1 (de)
EP (1) EP1503781B1 (de)
AT (1) ATE414538T1 (de)
AU (1) AU2003234245B2 (de)
CA (1) CA2484088A1 (de)
DE (1) DE60324784D1 (de)
WO (1) WO2003090773A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013455A1 (en) * 2006-07-27 2008-01-31 Lactive B.V. Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk
KR101080997B1 (ko) * 2009-02-06 2011-11-09 주식회사 단바이오텍 비만과 고지혈증 예방 및 치료를 위한 특이 난황항체를 포함하는 조성물
CN102869382A (zh) * 2010-06-10 2013-01-09 (株)Ad生物技 通过抑制肠内胆固醇吸收而抑制高脂血症和肥胖症的组合物
US10645990B2 (en) * 2013-08-19 2020-05-12 Nike, Inc. Article of footwear with adjustable sole
US10681957B2 (en) * 2015-09-17 2020-06-16 Daniel Thomas Duarte Suspension bridging shoe
US20180319894A1 (en) * 2015-11-03 2018-11-08 Mayo Foundation For Medical Education And Research Using colipase inhibitors to treat pancreatitis
JP7224331B2 (ja) 2017-07-12 2023-02-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 脂肪毒性損傷の低減のための化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4550019A (en) * 1978-03-22 1985-10-29 South Africa Inventions Development Corporation Manufacture and use of fowl egg antibodies
US5147638A (en) * 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5367054A (en) * 1993-04-12 1994-11-22 Stolle Research & Development Corp. Large-scale purification of egg immunoglobulin
NZ278607A (en) * 1994-02-07 1999-05-28 Knoll Ag Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above
AU2678997A (en) * 1996-04-19 1997-11-12 Lexigen Pharmaceuticals Corp. Inhibition of the binding of human ige to its receptor by tetracyclic compounds for the alleviation of ige-mediated immune response
FR2758143B1 (fr) * 1997-01-07 1999-02-19 Laphal Laboratoire De Pharmaco Inhibiteurs specifiques de la lipase pancreatique et leurs applications
US7344713B1 (en) * 1997-07-07 2008-03-18 Pimentel Julio L Decreased fat absorption with an anti-lipase antibody
US20030037350A1 (en) * 1999-09-29 2003-02-20 Millennium Pharmaceuticals, Inc. Novel nucleic acid sequences encoding a human ubiquitin protease, lipase, dynamin, short chain dehydrogenase, and ADAM-TS metalloprotease and uses therefor
CN1301849A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——共脂肪酶12和编码这种多肽的多核苷酸
EP1134231B1 (de) * 2000-03-14 2009-04-15 Unilever N.V. Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
CN1343711A (zh) * 2000-09-19 2002-04-10 上海博德基因开发有限公司 一种新的多肽——人共脂肪酶蛋白9.02和编码这种多肽的多核苷酸

Also Published As

Publication number Publication date
EP1503781A1 (de) 2005-02-09
DE60324784D1 (de) 2009-01-02
EP1503781B1 (de) 2008-11-19
CA2484088A1 (en) 2003-11-06
AU2003234245A1 (en) 2003-11-10
EP1503781A4 (de) 2006-02-22
AU2003234245B2 (en) 2006-08-03
US20040018197A1 (en) 2004-01-29
WO2003090773A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200901442A1 (ru) Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
MX2007003013A (es) Amidas biciclicas como inhibidores de cinasa.
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
ATE494904T1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
DE602007004615D1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
ATE453642T1 (de) Substituierte phenylaminopyrimidine
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
ATE396697T1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
ATE447948T1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen
ATE414538T1 (de) Behandlung zur reduzierung der zunahme des körpergewichts
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
GB0606805D0 (en) Organic compounds
FR2842422B1 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties